Monalizumab Human Monoclonal Antibody
Monalizumabis a research-grade recombinant antibody targeting CD159. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
KLRC1, NKG2-A/NKG2-B type II integral membrane protein, NKG2-A/B-activating NK receptor, CD159 antigen-like family member A, CD159a, NK cell receptor A, NKG2A
UniProt
P26715
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG4-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx334331-01 20 µg
Xin actin-binding repeat-containing protein 2 (XIRP2) Antibody
Sign In for Pricing
View Details abx334331-02 50 µg
Xin actin-binding repeat-containing protein 2 (XIRP2) Antibody
Sign In for Pricing
View Details abx334331-03 100 µg
Xin actin-binding repeat-containing protein 2 (XIRP2) Antibody
Sign In for Pricing
View Details abx334331-04 200 µg
Xin actin-binding repeat-containing protein 2 (XIRP2) Antibody
Sign In for Pricing
View Details abx334331-05 1 mg
Xin actin-binding repeat-containing protein 2 (XIRP2) Antibody
Sign In for Pricing
View Details 